Algernon Pharmaceuticalsinc (AGN.CN)
0.0800 x 23000 0.0950 x 105000
Post-market by (Cboe BZX)
0.0850 -0.0100 (-10.53%) 03/28/25 [CNSX]
0.0800 x 23000 0.0950 x 105000
Post-market 0.0850 unch (unch) 14:55 ET
for Fri, Mar 28th, 2025
Fiscal Year End Date: 08/31
(Values in thousands)
11-2024 | 08-2024 | 05-2024 | 02-2024 | 11-2023 | |
Assets | |||||
Current Assets | |||||
Cash & Cash Equivalents | 358 | 596 | 610 | 76 | 74 |
Receivables | 13 | 16 | 9 | 31 | 14 |
TOTAL | $426 | $739 | $687 | $123 | $122 |
Non-Current Assets | |||||
Intangibles | 3,200 | 3,177 | 3,177 | 3,802 | 3,801 |
Other Non-Current Assets | 29 | 29 | 29 | 29 | 29 |
TOTAL | $3,229 | $3,205 | $3,206 | $3,831 | $3,830 |
Total Assets | $3,655 | $3,944 | $3,893 | $3,954 | $3,951 |
Liabilities | |||||
Current Liabilities | |||||
Accounts payable and accrued liabilities | 1,839 | N/A | 1,759 | 3,176 | 2,867 |
TOTAL | $1,867 | $1,775 | $1,931 | $3,517 | $2,939 |
Non-Current Liabilities | |||||
TOTAL | $0 | $0 | $0 | $0 | $0 |
Total Liabilities | $1,867 | $1,775 | $1,931 | $3,517 | $2,939 |
Shareholders' Equity | |||||
Common Shares | 29,555 | 29,555 | 29,137 | 29,107 | 28,150 |
Retained earnings | -31,099 | -30,756 | -30,435 | -31,879 | -31,314 |
Other shareholders' equity | 3,332 | 3,369 | 3,260 | 3,209 | 4,177 |
TOTAL | $1,788 | $2,169 | $1,962 | $437 | $1,013 |
Total Liabilities And Equity | $3,655 | $3,944 | $3,893 | $3,954 | $3,951 |